Bioxytran Inc
(BIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 496 | 224 | 515 | 488 | 346 |
| Operating Income | -496 | -224 | -515 | -488 | -346 |
| Interest Expense | 47 | 45 | 32 | 24 | 20 |
| Other Income | 261 | 305 | -807 | -240 | -27 |
| Pre-tax Income | -283 | 35 | -1,354 | -752 | -392 |
| Net Income Continuous | -283 | 35 | -1,354 | -752 | -392 |
| Net Income | $-283 | $35 | $-1,354 | $-752 | $-392 |
| EPS Basic Total Ops | 0.00 | 0.00 | -0.02 | N/A | 0.00 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | -0.02 | -0.01 | 0.00 |
| EPS Diluted Total Ops | 0.00 | 0.00 | -0.02 | N/A | 0.00 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | -0.02 | -0.01 | 0.00 |
| EPS Diluted Before Non-Recurring Items | 0.00 | 0.00 | -0.02 | -0.01 | 0.00 |
| EBITDA(a) | $-492 | $-222 | $-513 | $137 | $-320 |